Fieldpoint Private Securities, LLC Corcept Therapeutics Inc Transaction History
Fieldpoint Private Securities, LLC
- $344 Million
- Q2 2022
A detailed history of Fieldpoint Private Securities, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 60 shares of CORT stock, worth $2,635. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60
Previous 80
25.0%
Holding current value
$2,635
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CORT
# of Institutions
311Shares Held
88.3MCall Options Held
1.07MPut Options Held
973K-
Black Rock Inc. New York, NY16.5MShares$727 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.55MShares$420 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.24MShares$362 Million11.51% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.91MShares$304 Million0.4% of portfolio
-
Parallel Advisors, LLC3.82MShares$168 Million3.2% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $4.71B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...